Prima BioMed (PBMD) – Analyst Ratings
-
Prima BioMed (PBMD): Positive safety results clear way for dose-escalation
-
Prima Biomed (PBMD) PT Lowered to $7 at Maxim Group, Buy Maintained as LAG-3 + Keytruda Moves to Higher Dose
-
-
-
-
-
-
-
-
-
-
Back to PBMD Stock Lookup